{"id":557994,"date":"2021-08-16T19:00:01","date_gmt":"2021-08-16T19:00:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=557994"},"modified":"2021-08-16T19:00:01","modified_gmt":"2021-08-16T19:00:01","slug":"revenues-from-global-sales-of-vocal-biomarkers-are-foreseen-to-surpass-us-390-mn-by-2027end","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/revenues-from-global-sales-of-vocal-biomarkers-are-foreseen-to-surpass-us-390-mn-by-2027end_557994.html","title":{"rendered":"Revenues from Global Sales of Vocal Biomarkers are Foreseen to Surpass US$ 390 Mn by 2027-end"},"content":{"rendered":"
\n
\"Revenues<\/a><\/div>\n
\n
Vocal Biomarker Market report by \u201cFact.MR \u2013 Market Research And Insights\u201d\n<\/div>\n<\/div>\n<\/div>\n
A recently compiled report of Fact.MR envisages the global sales of a vocal biomarkers to record a spectacular 23.3% CAGR between the forecast period 2018 and 2027<\/div>\n

Award winning market research company Fact.MR has conducted a study on the global vocal biomarker market. As per the analysis, recent breakthroughs in the healthcare sector has fostered the sales for vocal biomarkers. Long-term expansion prospects are expected to remain positive, experiencing high growth rate until 2027.<\/p>\n

According to the U.S. National Library of Medicine, there was a 39% of increase in the death rate due to the neurological disorder. Neurological disorders were the leading cause of DALYs (Disability Adjusted Life Years) and second leading cause of deaths. Hence, accelerating the production for vocal biomarkers<\/a>.<\/p>\n

According to the study, researchers are focusing on voice-based biomarkers. Start-ups are using Artificial Intelligence (AI) and machine learning (ML) to develop enhanced tools to detect a wide range of diseases. For instance, Vocalis Health, a start-up is working with developers to identify voice-based biomarkers for pulmonary hypertension.<\/p>\n

“Manufacturers are accelerating their research and development capacities for more enhanced technology to detect neurological diseases like Alzheimer’s and Parkinson’s. Healthcare professionals and manufacturing companies are using the AI and ML tools to propel the production for vocal biomarkers,” says the Fact.MR analyst. <\/em>  <\/p>\n

For More Valuable Information on Regional Market Dynamics, Request a Report Sample https:\/\/www.factmr.com\/connectus\/sample?flag=S&rep_id=719<\/a><\/strong><\/p>\n

\"vocal<\/p>\n

Key Takeaways<\/p>\n

<\/strong><\/p>\n